Copy Link Print Information

Tralokinumab

(Synonyms: CAT354)
2 Cited Publications
Revisión del cliente

Based on 2 publication(s) in Google Scholar

Tralokinumab (CAT354) is a humanized IgG4 monoclonal antibody that specifically binds to and neutralizes IL-13. Tralokinumab can be used in the research of diseases such as asthma, atopic dermatitis, and pulmonary fibrosis.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: 99.12%
  • No. CAS: 1044515-88-9
  • Peso molecular:144.14 kDa
  • Almacenamiento:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Tralokinumab
  • Experimental Validation Results for Tralokinumab
  • Experimental Validation Results for Tralokinumab
  • Experimental Validation Results for Tralokinumab
  • Tralokinumab Chemical Structure
    Tralokinumab Chemical Structure
No. CAS: 1044515-88-9
Tamaño
Precio
Stock
Cantidad
Amount: USD 0.00
Please select quantity
or
or

* Seleccione Cantidad antes de agregar artículos.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Tralokinumab Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Encuentre su distribuidor local Your local distributor: Hycultec GmbHHycultec
  • Actividad biológica
  • Chemical Information
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Tralokinumab

More
Customer Validation & Images
Cell Imaging/StainingIF
  • Cell Imaging/Staining
  • IF

Ver todos los productos específicos de isoformas Interleukin Related

More

Ver todos los productos específicos de isoformas Caspase

More
Keywords
MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Inicie sesiòn
Registrar
Sign in to MedChemExpress
Registrar una cuenta nueva

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    Human IgG4 lambda

  • 1/16

    Tralokinumab (HY-P99053) neutralizes Recombinant Human IL-13 (HY-P70568) induced proliferation in the TF-1 human erythroleukemic cell line. The Neutralization Dose (ND50) for this effect is 0.6630 μg/mL in the presence of 10 ng/mL Recombinant Human IL-13.

  • 1/16

    Tralokinumab purchased from MedChemExpress. Usage Cited in: ACS Nano. 2025 Sep 16;19(36):32361-32373. [Abstract]

    Customer Validation
     Representative images of fibrosis-induced spheroids subjected to microfluidic deformation analysis, comparing untreated control, antifibrotic drug NTD, and anti-interleukin drugs TCZ, STX, DUP, and TRA. Mab (5 μg/mL, 1 d) were added, Scale bars indicate 100 μm.

  • 1/16

    Tralokinumab purchased from MedChemExpress. Usage Cited in: ACS Nano. 2025 Sep 16;19(36):32361-32373. [Abstract]

    Customer Validation
     Confocal fluorescence images showing the expression of collagen-1 and α-SMA in spheroids treated with NTD, TCZ, STX, DUP, and TRA. Mab (5 μg/mL, 1 d) were added, Scale bars indicate 100 μm.

  • Tralokinumab Chemical Structure
    1/16
  • Tralokinumab
  • Tralokinumab (HY-P99053) neutralizes Recombinant Human IL-13 (HY-P70568) induced proliferation in the TF-1 human erythroleukemic cell line. The Neutralization Dose (ND50) for this effect is 0.6630 μg/mL in the presence of 10 ng/mL Recombinant Human IL-13.